Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells
- PMID: 18587055
- PMCID: PMC2586046
- DOI: 10.1165/rcmb.2007-0368OC
Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells
Abstract
Human herpesvirus-8 (HHV-8) is the causative agent of Kaposi's sarcoma and is associated with the angioproliferative disorders primary effusion lymphoma and multicentric Castleman's disease. Evidence of HHV-8 infection within the pulmonary vasculature of patients with idiopathic pulmonary arterial hypertension (IPAH) has been described. We hypothesize that HHV-8 infection of pulmonary microvascular endothelial cells results in an apoptotic-resistant phenotype characteristic of severe pulmonary arterial hypertension. Our objective was to investigate the ability of HHV-8 to infect human pulmonary microvascular endothelial cells in vitro and characterize the phenotypic effect of this infection. Human pulmonary microvascular endothelial cells were exposed to HHV-8 using two methods (direct virus and co-culture technique). The presence of lytic and latent infection was confirmed. Changes in endothelial cell gene and protein expression and effects on cellular apoptosis were measured. HHV-8 can both lytically and latently infect primary human pulmonary microvascular endothelial cells in vitro. HHV-8 infection results in significant changes in gene expression, including alterations of pathways important to cellular apoptosis. HHV-8 infection also alters expression of genes integral to the bone morphogenic protein pathway, including down-regulation of bone morphogenic protein-4. Other genes previously implicated in the development of PAH are affected by HHV-8 infection, and cells infected with HHV-8 are resistant to apoptosis.
Figures










Similar articles
-
Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection.Cancer Res. 2004 Jan 1;64(1):72-84. doi: 10.1158/0008-5472.can-03-2767. Cancer Res. 2004. PMID: 14729610
-
Insulin-Like Growth Factor 2 Receptor Expression Is Promoted by Human Herpesvirus 8-Encoded Interleukin-6 and Contributes to Viral Latency and Productive Replication.J Virol. 2019 Feb 19;93(5):e02026-18. doi: 10.1128/JVI.02026-18. Print 2019 Mar 1. J Virol. 2019. PMID: 30541844 Free PMC article.
-
Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions.Mod Pathol. 2003 Feb;16(2):145-53. doi: 10.1097/01.MP.0000052374.61768.79. Mod Pathol. 2003. PMID: 12591967
-
Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.Herpes. 2003 Dec;10(3):72-7. Herpes. 2003. PMID: 14759339 Review.
-
[The discovery of three novel human viruses, human herpesviruses 6, 7, and 8].Bull Acad Natl Med. 1997 Jun-Jul;181(6):1009-22. Bull Acad Natl Med. 1997. PMID: 9453828 Review. French.
Cited by
-
Shiftless, a Critical Piece of the Innate Immune Response to Viral Infection.Viruses. 2022 Jun 20;14(6):1338. doi: 10.3390/v14061338. Viruses. 2022. PMID: 35746809 Free PMC article. Review.
-
Mechanisms of disease: pulmonary arterial hypertension.Nat Rev Cardiol. 2011 Jun 21;8(8):443-55. doi: 10.1038/nrcardio.2011.87. Nat Rev Cardiol. 2011. PMID: 21691314 Free PMC article. Review.
-
Infections in the immunosuppressed host.Ann Am Thorac Soc. 2014 Aug;11 Suppl 4(Suppl 4):S211-20. doi: 10.1513/AnnalsATS.201401-038PL. Ann Am Thorac Soc. 2014. PMID: 25148427 Free PMC article. Review.
-
C19ORF66 Broadly Escapes Virus-Induced Endonuclease Cleavage and Restricts Kaposi's Sarcoma-Associated Herpesvirus.J Virol. 2019 May 29;93(12):e00373-19. doi: 10.1128/JVI.00373-19. Print 2019 Jun 15. J Virol. 2019. PMID: 30944177 Free PMC article.
-
IRAV (FLJ11286), an Interferon-Stimulated Gene with Antiviral Activity against Dengue Virus, Interacts with MOV10.J Virol. 2017 Feb 14;91(5):e01606-16. doi: 10.1128/JVI.01606-16. Print 2017 Mar 1. J Virol. 2017. PMID: 27974568 Free PMC article.
References
-
- Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:13S–24S. - PubMed
-
- Voelkel NF, Cool C, Lee SD, Wright L, Geraci MW, Tuder RM. Primary pulmonary hypertension between inflammation and cancer. Chest 1998;114:225S–230S. - PubMed
-
- Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA III, Loyd JE, Nichols WC, Trembath RC. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 2000;26:81–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases